Sciele Pharma News

Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series)
Increasingly, new technologies are making it possible to carefully identify sets of patien
Active Directory & the Cloud for Biotech & Pharma
Biotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
Webinar: Next Gen Sequencing from FFPE Samples
Next generation sequencing (NGS) technologies hold enormous promise to advance personalize
Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine Act
Beginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ

July 10, 2009 — 7:26am ET | By Maureen Martino

Citing an "unforeseen development" that occurred after the deal was signed, Shionogi & Co said its subsidiary Sciele Pharma would not go through will its planned buyout of Victory Pharma. In May, Read more...

Free Newsletter